European Commission logo
italiano italiano
CORDIS - Risultati della ricerca dell’UE
CORDIS

Biomarkers established to stratify sepsis long-term adverse effects to improve patients’ health and quality of life

Descrizione del progetto

Cercare soluzioni per combattere la sepsi

La sepsi, una condizione pericolosa per la vita causata da un’infezione, colpisce ogni anno quasi 50 milioni di persone: una sfida significativa per la salute globale e una delle principali cause di morte in tutto il mondo. I sopravvissuti spesso subiscono un’immunosoppressione post-sepsi, che li rende vulnerabili a infezioni, malattie autoimmuni e altri problemi di salute a lungo termine. Le complessità molecolari che guidano questa disfunzione immunitaria rimangono in gran parte elusive, complicando la prognosi e il trattamento. In questo contesto, il progetto BEATsep, finanziato dall’UE, sta unendo esperti medici e immunologi in tutta Europa. Tracciando marcatori clinici e immunologici unici nel tempo, BEATsep mira a svelare i misteri dell’immunosoppressione post-sepsi. La missione? Individuare i pazienti a rischio, decodificare i meccanismi molecolari sottostanti e sperimentare strategie di intervento precoce.

Obiettivo

Sepsis is a life-threatening organ dysfunction resulting from dysregulated immune responses to infection, affecting almost 50 million people yearly. Sepsis is a major global health challenge and a leading cause of death worldwide. Moreover, people surviving sepsis often suffer post-sepsis immunosuppression, a long-lasting state of immune dysfunction predisposing them to infections, autoimmune and non-communicable diseases (NCDs), and long-term reduced fitness. The molecular mechanisms driving post-sepsis immunosuppression remain largely elusive. Furthermore, predicting which patients will survive or develop immunosuppression is currently impossible.
BEATsep will tackle this challenge by combining the expertise of physicians, clinician scientists and immunologists in top European institutions. We will, for the first time, longitudinally assess unique immunological and clinical parameters and combine them to: i) gain insight into the long-term immunological consequences of septic shock; ii) identify novel markers to identify patients at risk; and iii) unravel molecular mechanisms driving post-sepsis immunosuppression. We will also develop strategies to improve the stratification of acute sepsis survivors to identify patients with a higher risk of sepsis-associated NCDs and comorbidities. BEATsep will have significant societal, scientific, and economic impacts, as efficient prevention of sepsis-induced comorbidities could save significant amounts within healthcare budgets and potentially improve the quality of life for millions worldwide who suffer from the long-term effects of sepsis.

Coordinatore

FAKULTNI NEMOCNICE U SV ANNY V BRNE
Contribution nette de l'UE
€ 1 872 875,00
Indirizzo
PEKARSKA 53
602 00 Brno
Cechia

Mostra sulla mappa

Regione
Česko Jihovýchod Jihomoravský kraj
Tipo di attività
Higher or Secondary Education Establishments
Collegamenti
Costo totale
€ 1 872 875,00

Partecipanti (9)

Partner (1)